CIK 0001699031
- Non-accelerated filer
- Emerging growth company
GRAIL, Inc.
Sign in to watch- Ticker
- GRAL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 863673636
- Phone
- +1 833-694-2553
- Business address
- 250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
- Former names
- GRAIL, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $15,155,660
- in 8 filings, $10.5M under 10b5-1 plans
Net −$15,155,660. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-05 | Partridge Andrew John Chief Growth Officer | Sale | −7,873 | $146.39 | $1.2M | 155,865 |
| 2026-06-04 | Partridge Andrew John Chief Growth Officer | Sale | −1,491 | $61.08 | $91K | 163,738 |
Page 1 of 1 · 2 trades